{
  "Disease": [
    {"role": "user", "content": "Please identify the \"Disease\" entities in the following paragraph. Please present the valid entities as a Markdown table with one column \"Disease\". Make sure to present the entities precisely in the same words as in the original paragraph.\n\nParagraph: On the basis of the findings reported herein , a dose of 60 mg / m ( 2 ) of CCNU combined with 250 mg / m ( 2 ) of CTX ( divided over 5 days ) q 4 wk is tolerable in tumor - bearing dogs .\n\nLet's think step by step."},
    {"role": "assistant", "content": "| Disease |\n| --- |\n| tumor-bearing dogs |\n\nExplanation:\n\nIn the given paragraph, the term \"tumor-bearing dogs\" is the only expression that can be identified as a disease. A tumor is a type of abnormal growth that can be benign or malignant, and in this context, it refers to dogs suffering from a tumor or neoplasm. Therefore, \"tumor-bearing dogs\" is a valid disease entity."},
    {"role": "user", "content": "Please remove entities that do not clearly refer to \"Disease\" and present the valid entities as a Markdown table with one column \"Disease\".\n\nMake sure to present the entities precisely in the same words as in the original paragraph."},
    {"role": "assistant", "content": "| Disease |\n| --- |\n| tumor-bearing dogs |\n\nExplanation:\n\nIn the given paragraph, the term \"tumor-bearing dogs\" is the only expression that can be identified as a disease. The other terms, such as \"60 mg / m ( 2 ) of CCNU\" and \"250 mg / m ( 2 ) of CTX ( divided over 5 days ) q 4 wk\" refer to drug dosages and treatment regimens, not diseases. Therefore, the valid disease entity is \"tumor-bearing dogs.\""}
  ],
  "Chemical": [
    {"role": "user", "content": "Please identify the \"Chemical\" entities in the following paragraph. Please present the valid entities as a Markdown table with one column \"Chemical\". Make sure to present the entities precisely in the same words as in the original paragraph.\n\nParagraph: On the basis of the findings reported herein , a dose of 60 mg / m ( 2 ) of CCNU combined with 250 mg / m ( 2 ) of CTX ( divided over 5 days ) q 4 wk is tolerable in tumor - bearing dogs .\n\nLet's think step by step."},
    {"role": "assistant", "content": "| Chemical |\n| --- |\n| CCNU |\n| CTX |\n\nExplanation:\n\nCCNU and CTX are the only two chemical entities mentioned in the paragraph. CCNU stands for Lomustine, which is a nitrosourea compound used as an antineoplastic agent. CTX is an abbreviation for Cyclophosphamide, which is an alkylating agent used in cancer chemotherapy."},
    {"role": "user", "content": "Please remove entities that do not clearly refer to \"Chemical\" and present the valid entities as a Markdown table with one column \"Chemical\".\n\nMake sure to present the entities precisely in the same words as in the original paragraph."},
    {"role": "assistant", "content": "| Chemical |\n| --- |\n| CCNU |\n| CTX |\n\nExplanation:\n\nCCNU and CTX are the only two chemical entities mentioned in the paragraph. CCNU stands for Lomustine, which is a nitrosourea compound used as an antineoplastic agent. CTX is an abbreviation for Cyclophosphamide, which is an alkylating agent used in cancer chemotherapy. The other terms in the paragraph, such as \"dose,\" \"mg/m2,\" \"divided over 5 days,\" \"q 4 wk,\" and \"tumor-bearing dogs\" do not refer to chemicals and are therefore not included in the table."}
  ]
}